SII hopes to launch new COVID-19 vaccine by June
[ad_1]
Covovax discovered to be 89.3% efficient in a U.K. trial
Serum Institute of India (SII) chief Adar Poonawalla on Saturday mentioned he’s hopeful of launching a new COVID-19 vaccine below the model identify Covovax by June. The Institute had earlier utilized for clearance to conduct a trial for the vaccine in India.
Covovax is being developed by American firm Novavax.
The vaccine was discovered to be 89.3% efficient in a U.K. trial and was almost as efficient in defending in opposition to the U.K. variant. Mr. Poonawalla has mentioned the SII’s partnership with Novavax, a vaccine present process trials for effectiveness in opposition to the novel coronavirus, has revealed “excellent efficacy results”.
Taking to Twitter, Mr. Poonawalla wrote, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”
Apart from Covovax, 4 extra vaccines are within the pipeline for India.
